Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-023540
Filing Date
2025-11-14
Accepted
2025-11-14 16:31:12
Documents
52
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 832183
2 EX-31.1 ex31-1.htm EX-31.1 10257
3 EX-31.2 ex31-2.htm EX-31.2 10384
4 EX-32.1 ex32-1.htm EX-32.1 9636
  Complete submission text file 0001493152-25-023540.txt   4243942

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20250930.xsd EX-101.SCH 36716
6 XBRL CALCULATION FILE envb-20250930_cal.xml EX-101.CAL 44735
7 XBRL DEFINITION FILE envb-20250930_def.xml EX-101.DEF 132309
8 XBRL LABEL FILE envb-20250930_lab.xml EX-101.LAB 308404
9 XBRL PRESENTATION FILE envb-20250930_pre.xml EX-101.PRE 218791
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 563110
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 251487163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)